MEDX Xelerator

Incubator Active Or Yehuda, Israel Est. 2016
Last updated 2026-06-18
Portfolio
15
in our dataset
Rounds participated
18
Rounds led
5
Rounds' value
$13.8M
total disclosed, rounds participated
Stages
Pre-Seed, Seed, A Round

About

MEDX Xelerator is a medical device and digital health-focused incubator operating under the auspices of the Israel Innovation Authority (IIA). Current partners and collaborators include: Boston Scientific, Sheba Medical Center, MEDX Venture Group, Consensus Business Group (CBG), West Pharmaceuticals and The Portland Trust. In cooperation with its partners and collaborators, MEDX Xelerator identifies and nurtures high impact medical ventures that fill major, unmet clinical needs with big markets, to benefit patients, physicians and investors alike. The incubator’s management team works closely with the portfolio companies to consistently achieve outstanding clinical and business milestones in a capital efficient way.

Portfolio · 15

Pylon Medical
Percutaneous Trans Carotid Stenting
Led ★ 2 rounds $1.2M committed Latest: 2024-07
LifeCord
Transfemoral Mitral Chordal Repair System
1 round $1.3M committed Latest: 2024-04
EyeMed Technologies
Premium Lens for Intraocular Implantation
2 rounds $800K committed Latest: 2023-11
Trilio-Medical
Transcatheter Implant for Tricuspid Valve Repair
Led ★ 1 round $2.1M committed Latest: 2022-11
NovaPulse
Treatment for Peripheral Artery Disease
1 round Latest: 2022-09
BeWeld Medical
Automating Manufacturing Processes of Implanted Devices
2 rounds $800K committed Latest: 2021-11
VeinWay
Advanced Vein Blockage Crossing Tools
1 round $800K committed Latest: 2021-05
SwiftDuct
Novel Endoscope for Safe and Accurate ERCP Procedures
Led ★ 1 round $800K committed Latest: 2020-10
Synchrony Medical
Airway Clearance System for Home Use
Led ★ 1 round $800K committed Latest: 2020-10
Dimoveo Medical
Internal Body Cavity Disinfection Technologies for Implants
Led ★ 1 round $800K committed Latest: 2020-10
CAPS Medical
Selective Minimally Invasive Treatment of Solid Tumors
1 round Latest: 2020-08
PatenSee
Stenosis Detection System for Patients Undergoing Dialysis
1 round $750K committed Latest: 2019-03
Exero Medical
Early Detection of Postoperative Anastomotic Leaks
1 round $2.1M committed Latest: 2018-11
Append Medical
Trans-septal Left Atrial Appendage Closure Device
1 round $800K committed Latest: 2018-06
Endoways
Self-propelling Microcatheter for Tortuous Blood Vessels
1 round $750K committed Latest: 2018-03

Investment activity

1 portfolio exit on record.

Portfolio by sector

Health Tech & Life Sciences14

Funds · 1

  • Edge Medical — $15M Sep 2024

Q&A

What is MEDX Xelerator's primary investment focus?
MEDX Xelerator is a medical device and digital health-focused incubator.
Which investment stages does MEDX Xelerator typically target?
MEDX Xelerator invests in Pre-Seed, Seed, and A Round stages.
Can you name a recent investment made by MEDX Xelerator?
In July 2024, MEDX Xelerator participated in a Seed round for Trilio-Medical, which raised $2.1M.
What is a notable portfolio company of MEDX Xelerator in the medical device space?
MEDX Xelerator has invested in Append Medical, which is developing a trans-septal left atrial appendage closure device and raised $12.55M in an A round.
Has MEDX Xelerator had any exits?
Yes, MEDX Xelerator had an exit in February 2021 when Endoways, a self-propelling microcatheter company, was acquired by Ascendum Capital.
What is the most recent fund raised by MEDX Xelerator?
MEDX Xelerator raised the Edge Medical fund in September 2024, with an amount of $15M.
Who is the CEO of MEDX Xelerator?
Shai Policker is the CEO of MEDX Xelerator.
What kind of companies does MEDX Xelerator seek to nurture?
MEDX Xelerator identifies and nurtures high-impact medical ventures that address major, unmet clinical needs with large markets.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)